机译:Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Headache Unit Neurology Department Vall d'Hebron University Hospital and Headache & Neurological;
Georgetown Headache Center Georgetown University Hospital;
Department of Neurology Danish Headache Center Copenhagen University Hospital - RigshospitaletNIHR King's Clinical Research Facility & Headache Group King's College LondonDepartment of Neurology and the Montefiore Headache Center Albert Einstein College of MedicineDepartment of Neurology Charité ? Universit?tsmedizin BerlinAbbVie;